Last reviewed · How we verify
Mitizodone Phosphate tablets — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Mitizodone Phosphate tablets (Mitizodone Phosphate tablets) — Sunshine Lake Pharma Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Mitizodone Phosphate tablets TARGET | Mitizodone Phosphate tablets | Sunshine Lake Pharma Co., Ltd. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Mitizodone Phosphate tablets CI watch — RSS
- Mitizodone Phosphate tablets CI watch — Atom
- Mitizodone Phosphate tablets CI watch — JSON
- Mitizodone Phosphate tablets alone — RSS
Cite this brief
Drug Landscape (2026). Mitizodone Phosphate tablets — Competitive Intelligence Brief. https://druglandscape.com/ci/mitizodone-phosphate-tablets. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing